Calendar Processa Pharmaceuticals, Inc.

Stocks

PCSA

US74275C4033

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-10-09 EDT			5-day change	1st Jan Change
1.520 ^USD	+12.59%		-5.59%	-47.22%

08-14	Processa Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-29	Processa Pharmaceuticals, Inc. announced that it has received $200 million in funding from a group of investors	CI

Chart calendar Processa Pharmaceuticals, Inc.

17aecbc95eb247fd9139cd06.twvAoOJkrlfN99oedyh9FbnBaPj5xmaVEJ21grC1xI4.2D2YztEm6Ri5nL1MFUQORv_0JpyzsyvGe7DW5P3fk8vPbJD5uzfJAp2hlw~931b0bb40cdfc8656157491a9395620d

Upcoming events on Processa Pharmaceuticals, Inc.

No events available

Past events on Processa Pharmaceuticals, Inc.

2026-07-30

Annual General Meeting

13:00

Past dividends on Processa Pharmaceuticals, Inc.

2025-12-17

Significant Split/Dividend

00:00

Annual results

Fiscal Period	December	2023	2024
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -
EBITDA	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -
EBIT Million USD	Released Forecast Spread	-11,5 -11,2 -2.63%	-12,1 -12,4 2.55%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-11,1 -10,9 -2.1%	-11,9 -12,2 2.48%
Net income Million USD	Released Forecast Spread	-11,1 -10,9 -2.1%	-11,9 -12,2 2.48%
EPS USD	Released Forecast Spread	-212 -213 0.24%	-96,8 -101 4.44%
Announcement Date		29/03/24	20/03/25

Quarterly results

Fiscal Period	June	2024 Q4	2025 Q1	2025 Q2	2025 Q3
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -
EBIT Million USD	Released Forecast Spread	-2,73 -3,05 10.34%	-2,85 -2,60 -9.58%	-3,95 -2,68 -47.2%	-3,49 -3,87 9.73%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-2,73 -3,03 9.94%	-2,83 -2,60 -9.1%	-3,93 -2,68 -46.73%	-3,44 -3,86 10.99%
Net income Million USD	Released Forecast Spread	-2,73 -3,03 9.94%	-2,83 -2,60 -9.1%	-3,93 -2,68 -46.73%	-3,44 -3,86 10.99%
EPS USD	Released Forecast Spread	-18,5 -23,0 19.57%	-7,50 -12,3 38.78%	-6,25 -5,50 -13.64%	-1,75 -2,00 12.5%
Announcement Date		20/03/25	08/05/25	07/08/25	06/11/25

Upcoming sector events for Processa Pharmaceuticals, Inc.

2026-10-13	GENFLEET THERAPEUTICS (SHANGHAI) INC.	Présentation aux Actionnaires / Analystes
2026-10-13	KURA ONCOLOGY, INC.	Information meeting	16:30
2026-10-13	HANCHORBIO INC.	Extraordinary General Meeting	22:00
2026-10-14	ARROWHEAD PHARMACEUTICALS, INC.	Information meeting	14:30
2026-10-14	GENFLEET THERAPEUTICS (SHANGHAI) INC.	Présentation aux Actionnaires / Analystes
2026-10-14	KUROS BIOSCIENCES AG	Sales and Revenue Release - Q3 2026
2026-10-14	VERASTEM, INC.	Information meeting	08:00
2026-10-21	HELUS PHARMA INC.	Information meeting	09:00
2026-10-22	ARGENX SE	Earnings release - Q3 2026
2026-10-23	TENNOR THERAPEUTICS (SUZHOU) LIMITED	Extraordinary General Meeting	02:00

More events

Past sector events for Processa Pharmaceuticals, Inc.

2026-10-07	GENMAB A/S	Extraordinary General Meeting	09:00
2026-10-07	GENMAB A/S	Présentation aux Actionnaires / Analystes	09:00
2026-10-06	FAETH THERAPEUTICS, INC.	Information meeting	10:00
2026-10-05	VAXCYTE, INC.	Information meeting	08:00
2026-10-01	NEKTAR THERAPEUTICS	Présentation aux Actionnaires / Analystes	08:00
2026-09-30	SAGIMET BIOSCIENCES INC.	Information meeting	13:00
2026-09-29	WUXI APPTEC CO., LTD.	Extraordinary General Meeting	02:00
2026-09-29	ZENAS BIOPHARMA, INC.	Information meeting	08:00
2026-09-29	UNIQURE N.V.	Information meeting	08:30
2026-09-29	IMMIX BIOPHARMA, INC.	Présentation aux Actionnaires / Analystes	08:00

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Processa Pharmaceuticals, Inc.

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - Processa Pharmaceuticals, Inc.

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Processa Pharmaceuticals, Inc.